RDTCF (Rapid Dose Therapeutics) Cyclically Adjusted FCF per Share: $-0.03 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RDTCF Rapid Dose Therapeutics Corp RDTCF
29 GF Score
Price $0.08
GF Value $0.25
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Rapid Dose Therapeutics Cyclically Adjusted FCF per Share?

Rapid Dose Therapeutics RDTCF +3.43% 29 Cyclically Adjusted FCF per Share is $-0.03 as of Feb. 2026. GuruFocus rates RDTCF with a GF Score™ of 29/100 and a GF Value™ of $0.25 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Rapid Dose Therapeutics's adjusted free cash flow per share for the three months ended in Feb. 2026 was $0.017. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.03 for the trailing ten years ended in Feb. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Rapid Dose Therapeutics was 28.30% per year. The lowest was 18.90% per year. And the median was 20.60% per year.

As of today (2026-07-22), Rapid Dose Therapeutics's current stock price is $0.0784. Rapid Dose Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Feb. 2026 was $-0.03. Rapid Dose Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


Rapid Dose Therapeutics  (OTCPK:RDTCF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Rapid Dose Therapeutics Cyclically Adjusted FCF per Share Related Terms


Rapid Dose Therapeutics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Rapid Dose Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics Cyclically Adjusted FCF per Share Chart

Rapid Dose Therapeutics Annual Data
Trend Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.01 0.00 -0.03

Rapid Dose Therapeutics Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.03 -0.03 -0.04 -0.03

RDTCF vs VRTX, REGN, ALNY: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Rapid Dose Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Dose Therapeutics Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Cyclically Adjusted Price-to-FCF falls into.


RDTCF
29GF Score
Rapid Dose Therapeutics Corp RDTCF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rapid Dose Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rapid Dose Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Feb. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Feb. 2026 (Change)*Current CPI (Feb. 2026)
=0.017/131.0772*131.0772
=0.017

Current CPI (Feb. 2026) = 131.0772.

Rapid Dose Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201509 0.025 100.421 0.033
201512 -0.011 99.947 -0.014
201603 -0.017 101.054 -0.022
201606 -0.001 102.002 -0.001
201609 0.001 101.765 0.001
201612 -0.012 101.449 -0.016
201703 -0.010 102.634 -0.013
201706 -0.012 103.029 -0.015
201709 -0.009 103.345 -0.011
201712 -0.011 103.345 -0.014
201809 0.000 105.636 0.000
201902 0.000 106.268 0.000
201905 -0.020 107.927 -0.024
201908 -0.033 108.085 -0.040
201911 -0.013 107.769 -0.016
202002 0.004 108.559 0.005
202005 0.000 107.532 0.000
202008 -0.004 108.243 -0.005
202011 -0.004 108.796 -0.005
202102 -0.010 109.745 -0.012
202105 -0.017 111.404 -0.020
202108 -0.006 112.668 -0.007
202111 -0.006 113.932 -0.007
202202 0.000 115.986 0.000
202205 -0.002 120.016 -0.002
202208 -0.003 120.569 -0.003
202211 -0.001 121.675 -0.001
202302 -0.001 122.070 -0.001
202305 -0.001 124.045 -0.001
202308 -0.001 125.389 -0.001
202311 -0.005 125.468 -0.005
202402 -0.009 125.468 -0.009
202405 -0.004 127.601 -0.004
202408 -0.002 127.838 -0.002
202411 -0.002 127.838 -0.002
202502 0.000 128.786 0.000
202505 -0.002 129.813 -0.002
202508 -0.001 130.208 -0.001
202511 -0.015 130.682 -0.015
202602 0.017 131.077 0.017

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.03 mean?
Rapid Dose Therapeutics (RDTCF) has a Cyclically Adjusted FCF per Share of $-0.03 as of Feb. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Rapid Dose Therapeutics and its competitors.
Is Rapid Dose Therapeutics' Cyclically Adjusted FCF per Share too high?
Rapid Dose Therapeutics' current Cyclically Adjusted FCF per Share is $-0.03. Overall, Rapid Dose Therapeutics has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rapid Dose Therapeutics' Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Rapid Dose Therapeutics' Cyclically Adjusted FCF per Share of $-0.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Rapid Dose Therapeutics and its competitors. Rapid Dose Therapeutics's current Cyclically Adjusted FCF per Share is $-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Dose Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Rapid Dose Therapeutics (RDTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.25, compared to a current price of $0.08 — trading 68.6% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $-0.03. Rapid Dose Therapeutics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Rapid Dose Therapeutics (RDTCF), the current Cyclically Adjusted FCF per Share is $-0.03 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rapid Dose Therapeutics (RDTCF) Overvalued in 2026?

Based on GuruFocus' analysis, Rapid Dose Therapeutics stock appears to be undervalued. The current stock price of $0.08 is trading 68.6% below its estimated GF Value™ of $0.25. GuruFocus considers Rapid Dose Therapeutics to be Possible Value Trap.

Key valuation signals for RDTCF:

  • Cyclically Adjusted FCF per Share: $-0.03
  • GF Value™: $0.25 vs. price of $0.08 (68.6% below fair value)
  • GF Score™: 29/100 with 3 warning signs

No single metric tells the full story. See the RDTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rapid Dose Therapeutics Business Description

Other Exchanges DOSE:Canada
Address 1121 Walkers Line, Unit 3a, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
29GF Score

Get the complete analysis for RDTCF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.25
GF Value